A Tobacco Control Policy & Legal Resource Center
Supporting Smokefree Air & Tobacco-Free Lives

CVS stock climbs 47% in the last 12 months, after stopping sales of tobacco (Associated Press)

Posted on

The nation’s second-largest drugstore chain said Tuesday that revenue from its biggest business, the pharmacy benefits management segment, jumped 12 percent to more than $24 billion, spurred in part by specialty drugs. ¬†CVS’ stock has climbed 17 percent since the beginning of the year, while the Standard & Poor’s 500 index has increased nearly 2 percent. The stock has increased 47 percent in the last 12 months.

Last year, CVS stopped selling tobacco because it is trying to burnish its image as a health care services provider.  Read more in the August 4 Associated Press Story.